Update shared on22 Aug 2025
Fair value Increased 5.33%Despite a notable reduction in consensus revenue growth forecasts, expectations for Anupam Rasayan India's earnings multiple have increased, resulting in a higher analyst price target now at ₹837.86.
What's in the News
- Board meeting scheduled to consider and approve unaudited Q1 FY26 financial results.
- Board approved providing a USD 17 million corporate guarantee for a credit facility availed by its wholly-owned subsidiary, Anupam General Trading FZE.
- Board to consider interim dividend declaration and approve allotment of 3,914,886 equity shares upon conversion of warrants.
- Signed a long-term Master Purchase Agreement with a major Japanese conglomerate, marking strategic expansion into the Japanese market.
- Entered a Letter of Intent with E-Lyte Innovations and FUCHS LUBRICANTS to potentially supply up to 1,500 TPA of lithium hexafluorophosphate for the battery chemicals market, with commercial deliveries targeted from FY27.
Valuation Changes
Summary of Valuation Changes for Anupam Rasayan India
- The Consensus Analyst Price Target has risen from ₹795.43 to ₹837.86.
- The Consensus Revenue Growth forecasts for Anupam Rasayan India has significantly fallen from 26.5% per annum to 19.3% per annum.
- The Future P/E for Anupam Rasayan India has significantly risen from 32.94x to 37.65x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.